Clinical trials: Allergen Immunotherapy in Elderly Patients
Allergen Immunotherapy in Elderly Patients
House Dust Mite Injection Immunotherapy in Elderly Patients.
Background. Immunotherapy in elderly patients is controversial, and there is still not much evidences supporting this treatment's safety and efficacy in this population.
- Trial name
- HDMeld (NCT03209245)
- Testing
- Purethal Mites, monitoring of allergen specific IgE, monitoring of allergen specific IgG4
- Volunteers
- 58 people
- Sponsor
- Medical University of Silesia